Patents by Inventor Anita Reddy

Anita Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220323597
    Abstract: The present disclosure provides improved methods of treatment of NSCLC cancers using telisotuzumab vedotin.
    Type: Application
    Filed: April 6, 2022
    Publication date: October 13, 2022
    Inventors: Janet Yikai JIN, Philip B. KOMARNITSKY, Mirella LAZAROV, Anita REDDY
  • Patent number: 10344262
    Abstract: The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoietic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: July 9, 2019
    Assignee: Asterias Biotherapeutics, Inc.
    Inventors: Suyi Tseng, Anish Sen Majumdar, Kevin Nishimoto, Anita Reddy, Jane S. Lebkowski
  • Patent number: 9974792
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: May 22, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Publication number: 20170369842
    Abstract: The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoietic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.
    Type: Application
    Filed: February 6, 2017
    Publication date: December 28, 2017
    Inventors: Suyi Tseng, Anish Sen Majumdar, Kevin Nishimoto, Anita Reddy, Jane S. Lebkowski
  • Publication number: 20170258804
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Application
    Filed: May 24, 2017
    Publication date: September 14, 2017
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Patent number: 9687492
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: June 27, 2017
    Assignee: Gilead Sciences, Inc.
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Publication number: 20160362661
    Abstract: The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells, The invention also provides cell populations enriched for target cell populations which are the differentiated in vitro progeny of primate pluripotent stem cells.
    Type: Application
    Filed: January 11, 2016
    Publication date: December 15, 2016
    Inventors: Christopher O'Sullivan, Kevin Nishimoto, Anita Reddy
  • Publication number: 20150150881
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Application
    Filed: December 3, 2014
    Publication date: June 4, 2015
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Publication number: 20140329314
    Abstract: The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells, The invention also provides cell populations enriched for target cell populations which are the differentiated in vitro progeny of primate pluripotent stem cells.
    Type: Application
    Filed: March 28, 2012
    Publication date: November 6, 2014
    Inventors: Christopher O'Sullivan, Kevin Nishimoto, Anita Reddy
  • Publication number: 20120107931
    Abstract: The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoeitic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.
    Type: Application
    Filed: December 6, 2011
    Publication date: May 3, 2012
    Applicant: Geron Corporation
    Inventors: Suyi Tseng, Anish Sen Majumdar, Kevin Nishimoto, Anita Reddy, Jane S. Lebkowski
  • Patent number: 8093049
    Abstract: The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoietic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: January 10, 2012
    Assignee: Geron Corporation
    Inventors: Suyi Tseng, Anish Sen Majumdar, Kevin Nishimoto, Anita Reddy, Jane S. Lebkowski
  • Publication number: 20090246869
    Abstract: The invention provides methods of differentiating primate pluripotent stem cells into cells of hematopoietic lineage. The invention further provides hematopoietic lineage cells differentiated from primate pluripotent stem cells, as well as methods of using the same and kits comprising the same.
    Type: Application
    Filed: March 26, 2009
    Publication date: October 1, 2009
    Applicant: Geron Corporation
    Inventors: Suyi Tseng, Anish Sen Majumdar, Kevin Nishimoto, Anita Reddy, Jane S. Lebkowski